HDFC Manufacturing Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

HDFC Manufacturing Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

HDFC Manufacturing Fund - Direct (G)

7.92%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

HDFC Bank Limited & Citibank N.A

Computer Age Management Services Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

10327.97

0.39

11.743

April 26, 2024

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

-

-

7.92 %

14.01 %

19.35 %

7.4 %

Rakesh Sethia

CFA, FRM, MBA, BBM

Over 17 years of experience in equity research

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right